Hepatitis B

Hepatitis B is one type of hepatitis – a liver disease- caused by the hepatitis B virus (HBV). Hepatitis B spreads by contact with an infected person's blood, semen or other body fluid. An infected woman can give hepatitis B to her baby at birth.

What is Hepatitis B?

Hepatitis B is a viral infection of the liver that is spread when contact is made with blood or blood products from an infected individual.

Hepatitis B Mechanisms

Hepatitis B Diagnosis

Hepatitis B Prevention

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

DNA-based nanorobotic hand could block viruses and enable rapid diagnostics

A tiny, four-fingered "hand" folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them, University of Illinois Urbana-Champaign researchers report.

27 Nov 2024

Innovative tool enhances the accuracy of predicting survival outcomes for liver failure patients

Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese Acute-on-Chronic Liver Failure Consortium (CATCH-LIFE)-MELD score).

26 Nov 2024

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.

15 Nov 2024

Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis

Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers.

12 Nov 2024

Research shows low vaccination rates for hepatitis A and B in men who have sex with men

Research analyzing European survey data from 113,884 men who have sex with men (MSM) and published in Eurosurveillance indicates that while most MSM have a basic understanding of viral hepatitis, only 44% report having been vaccinated against both hepatitis A and B.

8 Nov 2024

Hexavalent vaccine can reduce spread of whooping cough

Comprehensive coverage of the hexavalent vaccine can protect against whooping cough and polio, averting disease resurgence, writes Esther Nakkazi.

7 Nov 2024

Advancing vaccine development through green biotechnology

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

6 Nov 2024

Ratiometric fluorescent probes for measuring active albumin in liver disease patients

Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological activity.

29 Oct 2024

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore whether TMF affects blood lipids during 48 weeks in patients with CHB.

26 Oct 2024

Evaluating the effectiveness of GAAD for early detection of hepatocellular carcinoma

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis.

25 Oct 2024

Cardiovascular risks of COVID-19 antivirals

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing these drugs to high-risk patients.

16 Sep 2024

Global and Local Efforts to Take Action Against Hepatitis

In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the Coalition for Global Hepatitis Elimination (CGHE), and James Amugsi, a Mandela Washington Fellow and Physician Assistant at Sandema Hospital in Ghana. Together, they provide valuable insights into the challenges, successes, and the importance of partnerships in the fight against hepatitis.

20 Aug 2024

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Researchers investigated the relationship between state COVID-19 vaccination mandates for healthcare workers and vaccination rates among them.

19 Aug 2024

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Routine childhood vaccinations among children born between 1994 and 2023 have prevented millions of illnesses and deaths in the U.S., saving $540 billion in direct costs and $2.7 trillion in societal costs.

12 Aug 2024

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Research paper reviews the efficacy of the first licensed malaria vaccines, RTS,S and R21, highlighting their potential to significantly reduce childhood mortality and discussing future vaccine development strategies.

21 Jul 2024

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.

16 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

11 Jul 2024

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells blood vessels in the liver start a "sleep timer" that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies.

11 Jul 2024

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Hepatocellular carcinoma (HCC) is a primary liver cancer predominantly arising from chronic liver diseases such as hepatitis B and C infections, alcohol abuse, and metabolic disorders.

2 Jul 2024

Hepatitis B

Overview

Hepatitis B Mechanisms

Hepatitis B Diagnosis

Hepatitis B Prevention

Feature Articles

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

DNA-based nanorobotic hand could block viruses and enable rapid diagnostics

Innovative tool enhances the accuracy of predicting survival outcomes for liver failure patients

Duke-NUS team develops test to monitor engineered T cells in cancer treatment

Imbalances in NET homeostasis linked to portal vein thrombosis in CHB-related decompensated cirrhosis

Research shows low vaccination rates for hepatitis A and B in men who have sex with men

Hexavalent vaccine can reduce spread of whooping cough

Advancing vaccine development through green biotechnology

Ratiometric fluorescent probes for measuring active albumin in liver disease patients

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

Evaluating the effectiveness of GAAD for early detection of hepatocellular carcinoma

Cardiovascular risks of COVID-19 antivirals

Global and Local Efforts to Take Action Against Hepatitis

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

40% of US cancer cases linked to lifestyle choices

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hepatitis B

Overview

Feature Articles

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in